ALX Oncology Holdings Q4 EPS $(0.93) Misses $(0.86) Estimate
Portfolio Pulse from Happy Mohamed
ALX Oncology Holdings (NASDAQ:ALXO) reported Q4 earnings with losses of $(0.93) per share, missing the consensus estimate of $(0.86) by 8.14%. This represents a 55% increase in losses compared to $(0.60) per share from the same period last year.
March 07, 2024 | 9:23 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ALX Oncology Holdings reported a larger than expected quarterly loss, missing analyst estimates.
Missing the earnings estimate by a significant margin and reporting a 55% increase in losses year-over-year is likely to negatively impact investor sentiment and could lead to a short-term decrease in ALXO's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100